The availability of maternal serum alpha-fetoprotein (AFP) values from neural tube defect screening programmes offers the opportunity to improve the effectiveness of screening for Down syndrome. By appropriately combining information on maternal serum AFP and maternal age fewer women would need an a
AFP SCREENING AND DOWN SYNDROME
β Scribed by Baumgarten, A.
- Book ID
- 123600371
- Publisher
- The Lancet
- Year
- 1985
- Tongue
- English
- Weight
- 168 KB
- Volume
- 325
- Category
- Article
- ISSN
- 0140-6736
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In this study we report a new triple test that combines serum AFP, urine β€-core fragment of hCG, total urine estriol, and maternal age for calculating individual Down syndrome odds in the second trimester. The urine β€-core fragment/estriol ratio was used as a single screening variable. Analyte level
Biochemical screening for Down syndrome (DS) is well established in the second trimester of pregnancy, but there is little information available on its value in the first trimester. This study describes our preliminary results with biochemical screening for DS in the first trimester of pregnancy in